QT Prolongation in Critically Ill Patients With SARS-CoV-2 Infection

Coronavirus disease 2019 (COVID-19) and QTc prolongation

(2021) Khalid Changal et al.   BMC Cardiovascular Disorders

Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic

(2021) Geoffrey A. Rubin et al.   JAMA Network Open

Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart

(2021) Hanna Bräuninger et al.   CARDIOVASCULAR RESEARCH

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin

(2020) Ehud Chorin et al.   HEART RHYTHM

Experience with Hydroxychloroquine and Azithromycin in the COVID‐19 Pandemic: Implications for QT Interval Monitoring

(2020) Archana Ramireddy et al.   Journal of the American Heart Association

Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)

(2020) Nicholas J. Mercuro et al.   JAMA Cardiology

Incidence and determinants of QT interval prolongation in COVID‐19 patients treated with hydroxychloroquine and azithromycin

(2020) Ilir Maraj et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Characteristics of critically ill patients infected with COVID-19 in Abu Dhabi, United Arab Emirates

(2020) Khaled Abdallah et al.   Anaesthesia Critical Care & Pain Medicine

The impact of protocol‐based high‐intensity pharmacological thromboprophylaxis on thrombotic events in critically ill COVID‐19 patients

(2020) B. Atallah et al.   ANAESTHESIA

Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association

(2020) James E. Tisdale et al.   CIRCULATION

Thromboelastography findings in critically ill COVID-19 patients

(2020) Nouran Salem et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients

(2020) Vincenzo Russo et al.   Frontiers in Pharmacology

The genetics underlying acquired long QT syndrome: impact for genetic screening

(2015) Hideki Itoh et al.   EUROPEAN HEART JOURNAL